A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed ...
Poly(ADP-ribose) polymerase (PARP) inhibitors should be considered a treatment option for patients with uterine leiomyosarcomas harboring BRCA2 deep deletions, researchers advised. PARP inhibitors are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results